|
1
|
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).
|
J Hypertens
|
2007
|
20.09
|
|
2
|
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).
|
Eur Heart J
|
2007
|
9.43
|
|
3
|
[An invasive strategy in non-ST-segment elevation acute coronary syndromes. From large trials to the real world].
|
Rev Esp Cardiol
|
2004
|
2.03
|
|
4
|
[Use of sirolimus-eluting stents in complex lesions: clinical and angiographic follow-up].
|
Rev Esp Cardiol
|
2004
|
1.60
|
|
5
|
Validation of the SAMe-TT2R2 score in a nationwide population of nonvalvular atrial fibrillation patients on vitamin K antagonists.
|
Thromb Haemost
|
2015
|
1.49
|
|
6
|
[Emergency room risk stratification of patients with chest pain without ST segment elevation].
|
Rev Esp Cardiol
|
2003
|
1.46
|
|
7
|
[Treatment of acute myocardial infarction by primary angioplasty on-site compared with treatment following interhospital transfer: short- and long-time clinical outcomes].
|
Rev Esp Cardiol
|
2007
|
1.41
|
|
8
|
[Myocardial echocardiography with intracoronary injection of contrast in post-infarction patients. Implications and comparison with angiography and magnetic resonance imaging].
|
Rev Esp Cardiol
|
2004
|
1.40
|
|
9
|
Association between renal function and cardiovascular disease in patients with left ventricular hypertrophy. VIIDA study.
|
J Clin Hypertens (Greenwich)
|
2009
|
1.40
|
|
10
|
[Sex differences in mortality at one-month and at one-year after an acute coronary syndrome].
|
Med Clin (Barc)
|
2004
|
1.39
|
|
11
|
[Plasma concentration of big endothelin-1 and its relation with plasma NT-proBNP and ventricular function in heart failure patients].
|
Rev Esp Cardiol
|
2005
|
1.38
|
|
12
|
Blood pressure control in hypertensive women aged 65 years or older in a primary care setting. MERICAP study.
|
Rev Esp Cardiol
|
2011
|
1.38
|
|
13
|
Implantation of single-lead atrioventricular permanent pacemakers guided by electroanatomic navigation without the use of fluoroscopy.
|
Europace
|
2008
|
1.30
|
|
14
|
Characteristics and outcome of acute myocardial infarction in young patients. The PRIAMHO II study.
|
Cardiology
|
2006
|
1.13
|
|
15
|
Usefulness of an abnormal ankle-brachial index for detecting multivessel coronary disease in patients with acute coronary syndrome.
|
Rev Esp Cardiol
|
2010
|
0.95
|
|
16
|
Obese subjects with heart failure have lower N-terminal pro-brain natriuretic peptide plasma levels irrespective of aetiology.
|
Eur J Heart Fail
|
2005
|
0.91
|
|
17
|
[ESH/ESC 2007 Guidelines for the management of arterial hypertension].
|
Rev Esp Cardiol
|
2007
|
0.90
|
|
18
|
[Prognostic value of Charlson comorbidity index at 30 days and 1 year after acute myocardial infarction].
|
Rev Esp Cardiol
|
2004
|
0.90
|
|
19
|
Prognostic value of low ankle-brachial index in patients with hypertension and acute coronary syndromes.
|
J Hypertens
|
2009
|
0.87
|
|
20
|
[Acute myocardial infarction in patients under 45 years].
|
Rev Esp Cardiol
|
2002
|
0.87
|
|
21
|
Obese and nonobese patients with essential hypertension show similar N-terminal proBNP plasma levels.
|
Am J Hypertens
|
2008
|
0.86
|
|
22
|
Prognostic usefulness of white blood cell count on admission and one-year outcome in patients with non-ST-segment elevation acute chest pain.
|
Am J Cardiol
|
2006
|
0.86
|
|
23
|
Low lymphocyte count in acute phase of ST-segment elevation myocardial infarction predicts long-term recurrent myocardial infarction.
|
Coron Artery Dis
|
2010
|
0.86
|
|
24
|
Variability of NT-proBNP plasma and urine levels in patients with stable heart failure: a 2-year follow-up study.
|
Heart
|
2007
|
0.86
|
|
25
|
Usefulness of a comprehensive cardiovascular magnetic resonance imaging assessment for predicting recovery of left ventricular wall motion in the setting of myocardial stunning.
|
J Am Coll Cardiol
|
2005
|
0.86
|
|
26
|
Impact of clinical and subclinical peripheral arterial disease in mid-term prognosis of patients with acute coronary syndrome.
|
Am J Cardiol
|
2009
|
0.84
|
|
27
|
Combination of ankle brachial index and diabetes mellitus to predict cardiovascular events and mortality after an acute coronary syndrome.
|
Int J Cardiol
|
2010
|
0.84
|
|
28
|
Complete regression of cardiac non-Hodgkin lymphoma.
|
Int J Cardiol
|
2006
|
0.84
|
|
29
|
Variability of NT-proBNP and its relationship with inflammatory status in patients with stable essential hypertension: a 2-year follow-up study.
|
PLoS One
|
2012
|
0.83
|
|
30
|
Diagnostic and prognostic value of urine NT-proBNP levels in heart failure patients.
|
Eur J Heart Fail
|
2006
|
0.83
|
|
31
|
Inflammatory activation and left ventricular mass in essential hypertension.
|
Am J Hypertens
|
2009
|
0.81
|
|
32
|
Prognostic significance of heart rate in hospitalized patients presenting with myocardial infarction.
|
World J Cardiol
|
2012
|
0.81
|
|
33
|
Sex differences in the hypertensive population with chronic ischemic heart disease.
|
J Clin Hypertens (Greenwich)
|
2008
|
0.80
|
|
34
|
Soluble TNF-alpha and interleukin-6 receptors in the urine of heart failure patients. Their clinical value and relationship with plasma levels.
|
Eur J Heart Fail
|
2004
|
0.80
|
|
35
|
Usefulness of concomitant myoglobin and troponin elevation as a biochemical marker of mortality in non-ST-segment elevation acute coronary syndromes.
|
Am J Cardiol
|
2003
|
0.80
|
|
36
|
Risk stratification in non-ST elevation acute coronary syndromes: predictive power of troponin I, C-reactive protein, fibrinogen and homocysteine.
|
Int J Cardiol
|
2005
|
0.80
|
|
37
|
Plasma aldosterone and glomerular filtration in hypertensive patients with preserved renal function.
|
Rev Esp Cardiol
|
2010
|
0.79
|
|
38
|
[Prognostic value of white blood cell count in acute myocardial infarction: long-term mortality].
|
Rev Esp Cardiol
|
2005
|
0.79
|
|
39
|
Multimarker risk strategy for predicting 1-month and 1-year major events in non-ST-elevation acute coronary syndromes.
|
Am Heart J
|
2005
|
0.79
|
|
40
|
Impact of cardiovascular risk factors and inflammatory status on urinary 8-OHdG in essential hypertension.
|
Am J Hypertens
|
2011
|
0.79
|
|
41
|
High heart rate: more than a risk factor. Lessons from a clinical practice survey.
|
Int J Cardiol
|
2008
|
0.79
|
|
42
|
Prevalence of atrial fibrillation and use of antithrombotics in hypertensive patients aged >or=65 years. The FAPRES trial.
|
Rev Esp Cardiol
|
2010
|
0.79
|
|
43
|
[Magnitude and characteristics of residual lipid risk in patients with a history of coronary revascularization: the ICP-bypass study].
|
Rev Esp Cardiol
|
2011
|
0.79
|
|
44
|
[NT-proBNP levels and hypertension. Their importance in the diagnosis of heart failure].
|
Rev Esp Cardiol
|
2004
|
0.78
|
|
45
|
Left ventricular cavity area reflects N-terminal pro-brain natriuretic peptide plasma levels in heart failure.
|
Eur J Echocardiogr
|
2005
|
0.78
|
|
46
|
Prevalencia de fibrilación auricular y uso de fármacos antitrombóticos en el paciente hipertenso ≥ 65 años. El registro FAPRES.
|
Rev Esp Cardiol
|
2010
|
0.78
|
|
47
|
[Interleukin-4 and cardiac fibrosis in patients with heart failure].
|
Rev Esp Cardiol
|
2007
|
0.78
|
|
48
|
[Prevalence of primary aldosteronism in hypertensive patients and its effect on the heart].
|
Rev Esp Cardiol
|
2008
|
0.77
|
|
49
|
[Electrocardiographic criteria for left ventricular hypertrophy and cardiovascular risk in hypertensives. VIIDA study].
|
Rev Esp Cardiol
|
2007
|
0.77
|
|
50
|
[Influence of antecedent of hypertension in patients with acute coronary syndrome without ST elevation].
|
Med Clin (Barc)
|
2006
|
0.77
|
|
51
|
[Relationship between myocardial modelling and diastolic function in patients with essential hypertension].
|
Med Clin (Barc)
|
2011
|
0.77
|
|
52
|
Urinary B-type natriuretic peptide levels in the diagnosis and prognosis of heart failure.
|
J Card Fail
|
2007
|
0.77
|
|
53
|
Usefulness of NT-proBNP level for diagnosing left ventricular hypertrophy in hypertensive patients. A cardiac magnetic resonance study.
|
Rev Esp Cardiol
|
2008
|
0.76
|
|
54
|
Clinical profile and management of hypertensive patients with chronic ischemic heart disease and renal dysfunction attended by cardiologists in daily clinical practice.
|
J Hypertens
|
2008
|
0.76
|
|
55
|
Maximum longitudinal relaxation velocity of the left ventricle: its clinical value and relationship with NT-proBNP plasma levels in heart failure.
|
Echocardiography
|
2006
|
0.76
|
|
56
|
[How beta-blockers are used in Spain? Analysis of limitations in their use in internal medicine and cardiology: CARACTER-BETA study].
|
Rev Esp Cardiol
|
2011
|
0.76
|
|
57
|
Ventricular hypertrophy increases NT-proBNP in subjects with and without hypertension.
|
Int J Cardiol
|
2004
|
0.76
|
|
58
|
Impact of glomerular filtration rate on urinary BNP and NT-proBNP levels in heart failure.
|
Peptides
|
2012
|
0.76
|
|
59
|
Metformin and risk of long-term mortality following an admission for acute heart failure.
|
J Cardiovasc Med (Hagerstown)
|
2017
|
0.76
|
|
60
|
Cardiac incoordination induced by left bundle branch block: its relation with left ventricular systolic function in patients with and without cardiomyopathy.
|
Cardiovasc Ultrasound
|
2008
|
0.75
|
|
61
|
Importance of perception for blood pressure control.
|
Arch Intern Med
|
2008
|
0.75
|
|
62
|
[Hypertension in primary care. Are we aware of the magnitude of the problem and are we managing it properly?].
|
Rev Esp Cardiol
|
2005
|
0.75
|
|
63
|
[Atrio-ventricular block in Prinzmetal's angina refractary to medical treatment].
|
Med Clin (Barc)
|
2006
|
0.75
|
|
64
|
[Prognostic impact of anemia in acute heart failure].
|
Rev Invest Clin
|
2006
|
0.75
|
|
65
|
[8-hydroxy-2'-deoxyguanosine and lipid peroxidation in patients with heart failure].
|
Rev Esp Cardiol
|
2006
|
0.75
|
|
66
|
[Prognostic markers of non-ST elevation acute coronary syndromes].
|
Rev Esp Cardiol
|
2003
|
0.75
|
|
67
|
Urinary NT-proBNP. A valuable marker in the assessment of patients with essential hypertension.
|
Rev Esp Cardiol
|
2009
|
0.75
|
|
68
|
Importance of recognizing occult renal disease in hypertensive patients.
|
Rev Esp Cardiol
|
2009
|
0.75
|
|
69
|
[Independent role of C reactive protein to predict major events at one-month and at one-year in acute coronary syndrome without ST elevation].
|
Med Clin (Barc)
|
2004
|
0.75
|
|
70
|
Heart rate in acute heart failure, lower is not always better.
|
Int J Cardiol
|
2010
|
0.75
|
|
71
|
[Usefulness of trimetazidine in ischemia-reperfusion lesion. Experimental study in myocardial stunning model].
|
Arch Cardiol Mex
|
2005
|
0.75
|
|
72
|
[Immunological alterations and selectin values in hypertensive patients treated according to current criteria].
|
Med Clin (Barc)
|
2010
|
0.75
|
|
73
|
[NT-proBNP and atrioventricular plane displacement. Relationship and diagnostic implications].
|
Rev Esp Cardiol
|
2003
|
0.75
|
|
74
|
[Introduction].
|
Rev Esp Cardiol (Engl Ed)
|
2012
|
0.75
|